What if a relatively low-cost, repurposed drug could help treat multiple sclerosis (MS), the least treatable of all autoimmune diseases? That could be a distinct possibility now that Dr. Marcus Koch, MD, Ph.D., and Dr. Wee Yong, Ph.D., with Cummings School of Medicine...
University of Calgary Repurposed Drug Breakthrough: Hydroxychloroquine Delays Severe Forms of Multiple Sclerosis
read more